October 2018

The latest from Cogstate, leaders in optimizing the measurement of cognition

Cogstate to Present at the NORD Rare Diseases and Orphan Products Breakthrough Summit

October 11, 2018

Presentation to Outline Innovative Methodology for Developing Indication-Specific Outcome Measures in Rare Disease Clinical Trials New Haven, CT – October 11, 2018: The cognitive science company, Cogstate Ltd (ASX.CGS) today announced a presentation entitled, “Methodology for Development of Indication-Specific Outcome Measures in Rare Disease Trials: An Innovative Research Approach” will be delivered at the National […]